Operating EBITDA stood at INR 436 Cr, +18% YoY PAT for the quarter grew by +27% YoY to INR 291 Cr Gross Revenue stood at INR 1,719 Cr for Q1 FY24, +17% growth YoY & +5% growth QoQ Network Operating EBITDA was INR 436 Cr, growth
The company has consolidated its position in ASEAN, South America and Eastern Europe regions Venus Remedies has taken another decisive step towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region with the product registration from
According to a new research conducted by University of Dundee, combining ultrasound and MRI technology can help detect prostate cancer at an earlier stage and potentially save lives.The MULTIPROS study, led by Ghulam Nabi, Professor of Surgical Uro-oncology at the University’s School of Medicine, found that US/MRI
Revenue up by 15% QoQ and 17% YoY EBITDA up by 37% QoQ and 8% YoY Shalby Limited, India’s leading multi-specialty hospital, has announced its financial results for the quarter ending on June 30, 2023. Consolidated Performance Highlights: Consolidated Revenues of Rs. 2,400 million, growth of
The company has consolidated its position in GCC, ASEAN, Balkan and Caribbean regions with marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago for important chemotherapy drugs With this, the number of marketing approvals for its oncology products across 75 countries has gone
Scheduled to take place on September 1-2 at the prestigious Jio World Convention Centre in Mumbai. Expected attendance of approximately 1,000 industry professionals from 40 countries Agenda features a series of sessions that delve into digital solutions for various healthcare specialties, including Cardiology, Gynaecology,
Marking a major step in the global expansion strategy of Venus Remedies through its oncology products, this marketing authorisation from the largest GCC market will enable Venus Remedies to establish a strong foothold in GCC and MENA regions In a decisive step towards making its
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region with the product registration from Philippines for bleomycin, a widely used cancer drug Venus Remedies also expects the marketing authorisation
The recent catastrophic disaster in Turkey has left tens of thousands of people dead and thousands more injured. While the rescue phase is complete, the recovery and rehabilitation phase is just beginning. Many hospitals have been demolished and are not functional, and doctors, nurses, and
The hematological cancer therapy market is diverse and highly genericized, with chemotherapies currently accounting for the highest number of marketed drugs. However, the availability of more targeted and innovative therapies means that sales of antibodies, cell therapies and targeted therapies are all set to increase